This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: The Cleveland Clinic Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sang Hoon Han: Inventor of a SARS-CoV-2 Protease Inhibitor Patent.
Introduction
Sang Hoon Han is an inventor based in Cleveland, Ohio, associated with The Cleveland Clinic Foundation. His patent work concerns compounds designed to inhibit a key enzyme of SARS-CoV-2.
Latest Patents
Han is named on 1 patent, titled “Protease Inhibitors and Methods of Use.” The patent describes compounds that inhibit the 3C-like protease of SARS-CoV-2, along with pharmaceutical compositions containing those compounds and methods for using them to treat viral infections, including coronavirus infections.
Career Highlights
Han’s listed patent reflects research focused on potential therapeutic approaches to coronavirus infection. The disclosed compounds and methods center on inhibiting a viral protease, an enzyme involved in the virus’s life cycle.
Collaborations
The provided information lists Matthew R. Porter and Alice Hooper as Han’s coworkers. The patent is associated with The Cleveland Clinic Foundation.
Conclusion
Sang Hoon Han’s patent contribution highlights research into protease-inhibiting compounds and their potential use in treating SARS-CoV-2 and other viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile